CGMP-specific phosphodiesterase type 5

Enzyme that breaks down cGMP

cGMP-specific phosphodiesterase type 5 (PDE5) is an enzyme that plays a crucial role in the regulation of cyclic guanosine monophosphate (cGMP) levels in various tissues. It is a member of the phosphodiesterase family, which is responsible for the hydrolysis of cyclic nucleotides, such as cGMP and cyclic adenosine monophosphate (cAMP).

Function

PDE5 is primarily involved in the breakdown of cGMP, a secondary messenger that is important in many physiological processes, including vasodilation, smooth muscle relaxation, and platelet aggregation. By hydrolyzing cGMP to 5'-GMP, PDE5 regulates the intracellular concentration of cGMP and thus modulates the signaling pathways that depend on this molecule.

Distribution

PDE5 is widely distributed in the body, with high concentrations found in the corpus cavernosum of the penis, vascular smooth muscle, platelets, and visceral smooth muscle. Its presence in these tissues highlights its role in regulating blood flow and muscle tone.

Clinical Significance

PDE5 inhibitors, such as sildenafil (commonly known by the brand name Viagra), are used to treat erectile dysfunction and pulmonary arterial hypertension. These drugs work by inhibiting the action of PDE5, thereby increasing the levels of cGMP and enhancing the effects of nitric oxide-mediated vasodilation.

Counterfeit Viagra seized by U.S. Customs and Border Protection.

Mechanism of Action

The inhibition of PDE5 leads to an increase in cGMP levels, which promotes relaxation of smooth muscle and vasodilation. In the context of erectile dysfunction, this results in increased blood flow to the penis and facilitates erection. In pulmonary arterial hypertension, the increased cGMP levels lead to vasodilation of the pulmonary vasculature, reducing pulmonary blood pressure.

Pharmacology

PDE5 inhibitors are selective for the PDE5 enzyme, which minimizes their effects on other phosphodiesterases and reduces the risk of side effects. However, they can still interact with other medications and are contraindicated in patients taking nitrates due to the risk of severe hypotension.

Related pages

• Phosphodiesterase
• Sildenafil
• Erectile dysfunction
• Pulmonary arterial hypertension